 Carcinoma, Small Cell
"Carcinoma, Small Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)
| Descriptor ID |
D018288
|
| MeSH Number(s) |
C04.557.470.200.380
|
| Concept/Terms |
Carcinoma, Small Cell- Carcinoma, Small Cell
- Carcinomas, Small Cell
- Small Cell Carcinomas
- Oat Cell Carcinoma
- Small Cell Carcinoma
- Carcinoma, Oat Cell
- Carcinomas, Oat Cell
- Oat Cell Carcinomas
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Small Cell".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Small Cell".
This graph shows the total number of publications written about "Carcinoma, Small Cell" by people in this website by year, and whether "Carcinoma, Small Cell" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1981 | 3 | 0 | 3 | | 1982 | 1 | 0 | 1 | | 1983 | 1 | 2 | 3 | | 1984 | 1 | 1 | 2 | | 1985 | 6 | 1 | 7 | | 1986 | 4 | 0 | 4 | | 1987 | 1 | 1 | 2 | | 1988 | 8 | 3 | 11 | | 1989 | 2 | 1 | 3 | | 1990 | 5 | 1 | 6 | | 1991 | 5 | 0 | 5 | | 1992 | 2 | 1 | 3 | | 1993 | 3 | 0 | 3 | | 1994 | 3 | 1 | 4 | | 1995 | 3 | 0 | 3 | | 1996 | 4 | 2 | 6 | | 1997 | 2 | 0 | 2 | | 1998 | 1 | 1 | 2 | | 1999 | 1 | 1 | 2 | | 2001 | 1 | 0 | 1 | | 2002 | 1 | 0 | 1 | | 2003 | 1 | 0 | 1 | | 2005 | 1 | 1 | 2 | | 2009 | 1 | 1 | 2 | | 2010 | 0 | 1 | 1 | | 2016 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Carcinoma, Small Cell" by people in Profiles.
-
Kuan EC, Alonso JE, Tajudeen BA, Arshi A, Mallen-St Clair J, St John MA. Small cell carcinoma of the head and neck: A comparative study by primary site based on population data. Laryngoscope. 2017 08; 127(8):1785-1790.
-
Hollings DD, Higgins RS, Faber LP, Warren WH, Liptay MJ, Basu S, Kim AW. Age is a strong risk factor for atrial fibrillation after pulmonary lobectomy. Am J Surg. 2010 Apr; 199(4):558-61.
-
Kim AW, Faber LP, Warren WH, Basu S, Wightman SC, Weber JA, Bonomi P, Liptay MJ. Pneumonectomy after chemoradiation therapy for non-small cell lung cancer: does "side" really matter? Ann Thorac Surg. 2009 Sep; 88(3):937-43; discussion 944.
-
Hansel DE, Nakayama M, Luo J, Abukhdeir AM, Park BH, Bieberich CJ, Hicks JL, Eisenberger M, Nelson WG, Mostwin JL, De Marzo AM. Shared TP53 gene mutation in morphologically and phenotypically distinct concurrent primary small cell neuroendocrine carcinoma and adenocarcinoma of the prostate. Prostate. 2009 May 01; 69(6):603-9.
-
Mulshine JL, Sullivan DC. Clinical practice. Lung cancer screening. N Engl J Med. 2005 Jun 30; 352(26):2714-20.
-
Ettinger DS, Berkey BA, Abrams RA, Fontanesi J, Machtay M, Duncan PJ, Curran WJ, Movsas B, Byhardt RW. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study. J Clin Oncol. 2005 Aug 01; 23(22):4991-8.
-
Movsas B, Moughan J, Komaki R, Choy H, Byhardt R, Langer C, Goldberg M, Graham M, Ettinger D, Johnstone D, Abrams R, Munden R, Starkschall G, Owen J. Radiotherapy patterns of care study in lung carcinoma. J Clin Oncol. 2003 Dec 15; 21(24):4553-9.
-
Bonomi P. Matrix metalloproteinases and matrix metalloproteinase inhibitors in lung cancer. Semin Oncol. 2002 Feb; 29(1 Suppl 4):78-86.
-
Plesko I, Severi G, Obsitn?kov? A, Boyle P, Kub?k A. Lung cancer incidence rates by histologic type: an example of trends in Eastern Europe--Slovakia 1978-95. Neoplasma. 2001; 48(4):247-53.
-
Chaudhry A, Carrasquillo JA, Avis IL, Shuke N, Reynolds JC, Bartholomew R, Larson SM, Cuttitta F, Johnson BE, Mulshine JL. Phase I and imaging trial of a monoclonal antibody directed against gastrin-releasing peptide in patients with lung cancer. Clin Cancer Res. 1999 Nov; 5(11):3385-93.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|